脂肪性肝炎
FGF21型
荟萃分析
医学
非酒精性脂肪性肝炎
脂肪变性
内科学
生物信息学
脂肪肝
老年学
生物
疾病
非酒精性脂肪肝
成纤维细胞生长因子
受体
作者
Fabiana Dolovitsch de Oliveira,Samira Mohamad Khalil,Emmily Daiane Buarque de Santana Sato,Matheus Souza,Gilmara Coelho Meine
摘要
Fibroblast growth factor 21 (FGF21) analogues may benefit patients with metabolic dysfunction-associated steatohepatitis (MASH). We aimed to compare the efficacy and safety of FGF21 analogues versus placebo for treating patients with MASH in randomized controlled trials (RCTs).
科研通智能强力驱动
Strongly Powered by AbleSci AI